Vaccines comprising innovative adjuvants are rapidly reaching advanced translational
stages, such as the authorized nanotechnology adjuvants in mRNA vaccines against COVID …

There is a growing interest in the targeting of Toll-like receptors (TLRs) for the prevention
and treatment of cancer, rheumatoid arthritis, inflammatory bowel disease and systemic …

The majority of vaccine candidates in clinical development are highly purified proteins and
peptides relying on adjuvants to enhance and/or direct immune responses. Despite the …

Despite great advances in the field of vaccination, there are still needs for novel and
effective vaccines because still no effective vaccines have been produced for some …

The development and widespread application of vaccines has been one of the most
significant achievements of modern medicine. Vaccines have not only been instrumental in …

Vaccines, one of the most effective and powerful public health measures, have saved
countless lives over the past century and still have a tremendous global impact. As an …

Infectious diseases are responsible for an overwhelming number of deaths worldwide and
their clinical management is often hampered by the emergence of multi-drug-resistant …

The growing number of zika virus (ZIKV) infections plus a 20-fold increase in neonatal
microcephaly in newborns in Brazil have raised alarms in many countries regarding the …

Alzheimer's disease (AD) is a neurodegenerative disorder mainly characterized by amyloid-
β (Aβ) plaques, neurofibrillary tangles, loss of synapses and neurons and chronic …

Differentiation of naïve B cells, including immunoglobulin class-switch DNA recombination,
is critical for the immune response and depends on the extensive integration of signals from …